Improved and faster analysis of MR images

Thanks to a new software, MR images from a five-minute scan may generate the images for a complete and comprehensive examination and therefore eliminating the need to perform multiple scans. The advanced software developed by Synthetic MR AB will be offered as a clinical application in Sectra´s PACS system.

Using the approach of Synthetic MRI at first a rapid quantification sequence is...
Using the approach of Synthetic MRI at first a rapid quantification sequence is performed on the patient. From this single sequence, which only takes about 5 minutes to cover the head, T1 and T2 relaxation maps, proton density maps and B1 field inhomogeneity maps are retrieved.
Based on these maps any T1 weighted and T2 weighted image can be synthesized

We are highly impressed by the efficiency enhancement in magnetic resonance examinations that may potentially be achieved with Synthetic MR´s software,” says Torbjörn Kronander, President of Sectra Imtec AB. The company recently has signed a cooperation agreement with the Swedish research Company Synthetic MR AB with the result that Sectra now can offer the advanced software that provides time-savings for the patients, hospital personnel and technicians as well as facilitating and improving the analysis of MR images.

 The Concept of Synthetic Magnetic Resonance Imaging

A normal examination of clinical Magnetic Resonance Imaging (MRI) consists of the generation of a series of contrast images on a patient. The image pixel intensity of these contrast images depends on both patient specific MR tissue parameters, such as the longitudinal T1 relaxation, the transverse T2 relaxation and the proton density (PD), and on the other hand the MRI scanner settings with parameters such as the echo time (TE), the repetition time (TR), the flip angle and the application of preparation pulses. During an examination the scanner settings are predefined to particular values and subsequently the scan is performed. This procedure is repeated over and over again with different settings until all desired contrast images are acquired. This can be a time-consuming procedure, taking 45 - 60 minutes.

A better approach is the direct measurement of the absolute MR tissue parameters for tissue characterization. A quantitative measurement allows to estimate the absolute deviation from the normal and the progress of disease over time. Examples for the clinical relevance of absolute quantification are the use of T1 relaxation time for diseases such as Parkinson, Alzheimer and Multiple Sclerosis, or T2* relaxation time to assess iron deposition in e.g. thalassemia, or the use of several MR parameters for the characterization of atherosclerotic plaques.

In spite of the clinical benefits of MR tissue quantification its application is far from common clinical practice. The two most important reasons are the associated scan time for accurate quantification and the appearance of the data set. At the Center of Medical Imaging Science and Visualization (www.cmiv.liu.se) a rapid and flexible method for simultaneous quantification of the MR tissue parameters is developed in order to overcome the first hurdle. Instead of the usual multi-hour measurement a complete brain can now be accurately captured at high resolution in about 5 minutes which allows absolute quantification to enter the clinical arena. The second hurdle is addressed using the concept of Synthetic MRI. Based on the absolute MR tissue parameters it is possible to synthesize any T1 or T2 weighted contrast image that is common in clinical practice. This means that the mentioned 5 minutes scan may generate the images for a complete and comprehensive examination. The similarity of the synthetic images with the normal images will significantly lower the threshold for application of absolute quantification in MRI. Moreover, using this approach images can be optimized even if the patient has already left and it is even possible to visualize stronger, non-physical perceptualizations that cannot be generated on the MR scanner itself, e.g. Synthetic Vector MRI or Synthetic Color MRI.

The optimization of contrast images by means of Synthetic Contrast MRI, the visualization of various non-physical contrasts and the visualization of Synthetic Color MRI based on absolute tissue values are under patent. Currently the MR sequences for quantification are in their validation phase. Sites can licence the approach and get support. The expectation is that the MR community will quickly adopt Synthetic MRI as a diagnostic and research tool once a proper validation has been done.

06.01.2008

More on the subject:More on companies:
Read all latest stories

Related articles

Photo

IT security

What keeps a hospital’s immune system healthy?

‘You can’t get 100 percent security, you can’t avoid all risks – but you can improve security tremendously just by considering some rules,’ explains Torbjörn Kronander, Board member, CEO…

Photo

Digital Pathology

Take the next step in Digital Pathology

Digitizing pathology is not just a transformation of technology, the major change and benefits lies in the change to a more efficient workflow – enabled by the new technology.

Photo

Testing Bones

Osteoporosis risk assessments with DXR

Women over the age of 50 are not only at higher risk of developing breast cancer but also osteoporosis. Would it not be practical to use the same method to detect both diseases early on? Definitely,…

Related products

allMRI GmbH – MRI vacuum immobilisation for head coils

Accessories / Complementary systems

allMRI GmbH – MRI vacuum immobilisation for head coils

allMRI GmbH
allMRI GmbH – MRI wheelchair – foldable

Accessories / Complementary systems

allMRI GmbH – MRI wheelchair – foldable

allMRI GmbH
allMRI GmbH – MRI wheeled waste bin – 90 liters

Accessories / Complementary Systems

allMRI GmbH – MRI wheeled waste bin – 90 liters

allMRI GmbH
Block Imaging

3 Tesla

Block Imaging

Block Imaging
Canon – Vantage Elan

1.5 Tesla

Canon – Vantage Elan

Canon Medical Systems Europe B.V.
Canon – Vantage Galan 3 T

3 Tesla

Canon – Vantage Galan 3 T

Canon Medical Systems Europe B.V.